These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34021727)

  • 21. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
    Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
    Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer.
    He Z; Jiang H; Zhang X; Zhang H; Cui Z; Sun L; Li H; Qian J; Ma J; Huang J
    Pharmacol Res; 2020 Oct; 160():105184. PubMed ID: 32946931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of MHI148 Targeted Photodynamic Therapy and STING Activation Inhibits Tumor Metastasis and Recurrence.
    Yu H; Chen Q; Zheng M; Wang R; Wang H; Cheng L; Hu Y; Dai M; Du C; Luo W; Tan M; Cao Y; Guo Y; Ran H
    ACS Appl Mater Interfaces; 2024 Jun; 16(23):29672-29685. PubMed ID: 38813586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature.
    Xu H; Russell SN; Steiner K; O'Neill E; Jones KI
    Cancer Immunol Immunother; 2024 Aug; 73(10):204. PubMed ID: 39105848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cascade Immune Activation of Self-Delivery Biomedicine for Photodynamic Immunotherapy Against Metastatic Tumor.
    Zheng RR; Zhao LP; Yang N; Chen ZX; Kong RJ; Huang CY; Rao XN; Chen X; Cheng H; Li SY
    Small; 2023 Jan; 19(3):e2205694. PubMed ID: 36366925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Light-Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy.
    Choi J; Park B; Park JY; Shin D; Lee S; Yoon HY; Kim K; Kim SH; Kim Y; Yang Y; Shim MK
    Adv Mater; 2024 Sep; 36(38):e2405475. PubMed ID: 38898702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib.
    Sun X; Cao Z; Mao K; Wu C; Chen H; Wang J; Wang X; Cong X; Li Y; Meng X; Yang X; Yang YG; Sun T
    Biomaterials; 2020 May; 240():119845. PubMed ID: 32085974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer.
    Ghonim MA; Ibba SV; Tarhuni AF; Errami Y; Luu HH; Dean MJ; El-Bahrawy AH; Wyczechowska D; Benslimane IA; Del Valle L; Al-Khami AA; Ochoa AC; Boulares AH
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maitake α-glucan promotes differentiation of monocytic myeloid-derived suppressor cells into M1 macrophages.
    Masuda Y; Nakayama Y; Shimizu R; Naito K; Miyamoto E; Tanaka A; Konishi M
    Life Sci; 2023 Mar; 317():121453. PubMed ID: 36709912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
    Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
    Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive oxygen species/glutathione dual sensitive nanoparticles with encapsulation of miR155 and curcumin for synergized cancer immunotherapy.
    Li K; Wang J; Xie Y; Lu Z; Sun W; Wang K; Liang J; Chen X
    J Nanobiotechnology; 2024 Jul; 22(1):400. PubMed ID: 38972995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoliposomes co-encapsulating Ce6 and SB3CT against the proliferation and metastasis of melanoma with the integration of photodynamic therapy and NKG2D-related immunotherapy on A375 cells.
    Liu H; Yao C; Zhang L; Xin J; Zhang Z; Wang S
    Nanotechnology; 2021 Aug; 32(45):. PubMed ID: 34352746
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication.
    Song W; Kuang J; Li CX; Zhang M; Zheng D; Zeng X; Liu C; Zhang XZ
    ACS Nano; 2018 Feb; 12(2):1978-1989. PubMed ID: 29420012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin).
    Tanaka M; Kataoka H; Yano S; Sawada T; Akashi H; Inoue M; Suzuki S; Inagaki Y; Hayashi N; Nishie H; Shimura T; Mizoshita T; Mori Y; Kubota E; Tanida S; Takahashi S; Joh T
    Oncotarget; 2016 Jul; 7(30):47242-47251. PubMed ID: 27363018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effect of adoptive immunotherapy and docetaxel inhibits tumor growth in a mouse model.
    Hu Y; Liu J; Cui P; Liu T; Piao C; Xu X; Zhang Q; Xiao M; Lu Y; Liu X; Wang Y; Lu X
    Cell Immunol; 2020 Feb; 348():104036. PubMed ID: 31924315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeric Peptide-Engineered Self-Delivery Nanomedicine for Photodynamic-Triggered Breast Cancer Immunotherapy by Macrophage Polarization.
    Liu YB; Chen XY; Yu BX; Cen Y; Huang CY; Yan MY; Liu QQ; Zhang W; Li SY; Tang YZ
    Small; 2024 May; 20(22):e2309994. PubMed ID: 38095445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
    Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
    ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-specific activated photodynamic therapy with an oxidation-regulated strategy for enhancing anti-tumor efficacy.
    Liang H; Zhou Z; Luo R; Sang M; Liu B; Sun M; Qu W; Feng F; Liu W
    Theranostics; 2018; 8(18):5059-5071. PubMed ID: 30429886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy.
    Su Z; Xiao Z; Huang J; Wang Y; An Y; Xiao H; Peng Y; Pang P; Han S; Zhu K; Shuai X
    ACS Appl Mater Interfaces; 2021 Mar; 13(11):12845-12856. PubMed ID: 33709684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.